彩色多普勒超声在甲状腺相关眼病诊疗中的应用研究

发布时间：2018-06-21 18:19

本文选题：甲状腺相关性眼病 + 彩色多普勒超声　；参考：《中国地方病防治杂志》2017年08期

【摘要】：目的研究彩色多普勒超声(color Doppler flow imaging,CDFI)在甲状腺相关性眼病(thyroid associated ophthalmopathy,TAO)诊疗中临床意义。方法在2015年8月~2017年8月间进入我院就医的拟诊断为TAO患者中选择60例为TAO组,另随机选择55例双眼正常者作为对照组。并在TAO患者治疗的过程中进行随访,皆进行彩色多普勒检查,记录每次检查的内外直肌厚度、球后脂肪组织厚度以及视网膜中央动脉收缩期峰值流速(peak systolic velocity,PSV)。分别比较TAO组和对照组、TAO患者治疗前和治疗3个月后的超声相关参数。结果通过CDFI检查,TAO组患者的眼外肌明显变厚、回声减低(P0.05),偶见泪腺水肿;球后脂肪组织明显变厚且回声减低(P0.05);PSA明显变快(P0.05)。TAO患者治疗3个月后统计相关参数,TAO患者的眼外肌厚度及球后脂肪组织均明显变薄、回声稍增高(P0.05),PSV有减低(P0.05)。结论彩色多普勒超声在TAO的诊疗过程中有很大的临床价值。
[Abstract]:Objective to study the clinical significance of color Doppler flow imaging (CDFI) in the diagnosis and treatment of thyroid associated ophthalmopathy. Methods from August 2015 to August 2017, 60 patients with TAO were selected as TAO group and 55 patients with normal eyes as control group. All the patients were followed up by color Doppler. The thickness of the medial rectus muscle, the thickness of retrobulbar adipose tissue and the peak systolic velocity of central retinal artery were recorded. The ultrasonic parameters of TAO patients before and 3 months after treatment were compared between TAO group and control group. Results in the TAO group, the extraocular muscles became thicker, the echo was decreased (P0.05), and the lacrimal gland edema was occasionally observed by CDFI. The thickness of extraocular muscle and retrobulbar adipose tissue in TAO patients were obviously thickened and the PSA of hypoechoic P0.05 / TAO patients were obviously thickened after 3 months of treatment. P0.05 / PSV of TAO patients decreased P0.05 / PSV significantly after 3 months of treatment, and the thickness of extraocular muscle and retrobulbar adipose tissue of patients with TAO were significantly thinner than those of patients with TAO. Conclusion Color Doppler ultrasound has great clinical value in the diagnosis and treatment of TAO.
【作者单位】：海口市人民医院超声科;
【分类号】：R581;R77

【相似文献】